Share
Market Research Report

ORAL BIOLOGICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassGlucagon-like Peptide 1 (GLP-1) Receptor Agonist · Hormone · Recombinant Enzyme · Guanylate Cyclase-C Agonist · Somatostatin Analogue · Others
  • By Disease IndicationDiabetes · Hyperoxaluria · Acromegaly · Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC) · Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism, and Others)
  • By Distribution channelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In28 Apr 2026
  • Report CodeCMI989
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Disease Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Oral Biologics Market, By Drug Class, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Hormone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Recombinant Enzyme
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Guanylate Cyclase-C Agonist
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Somatostatin Analogue
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
  5. Global Oral Biologics Market, By Disease Indication, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Hyperoxaluria
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Acromegaly
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
    • Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism, and Others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
      • Segment Trends
  6. Global Oral Biologics Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  7. Global Oral Biologics Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2021 - 2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Novo Nordisk A/S
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biocon Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Oramed Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Rani Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Entera Bio Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Enteris BioPharma, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Chiasma, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Allena Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 26 figures on “Global Oral Biologics Market”-Global forecast to 2033